Rho Capital Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,067,892
| Closed | -$57.1M | – | 10 |
|
|
2016
Q1 | $57.1M | Hold |
1,067,892
| – | – | 31.25% | 1 |
|
|
2015
Q4 | $121M | Hold |
1,067,892
| – | – | 41.48% | 1 |
|
|
2015
Q3 | $126M | Hold |
1,067,892
| – | – | 41.75% | 1 |
|
|
2015
Q2 | $82.7M | Hold |
1,067,892
| – | – | 28.91% | 1 |
|
|
2015
Q1 | $61.8M | Hold |
1,067,892
| – | – | 25.76% | 2 |
|
|
2014
Q4 | $34.4M | Hold |
1,067,892
| – | – | 15.28% | 3 |
|
|
2014
Q3 | $26.1M | Hold |
1,067,892
| – | – | 13.12% | 3 |
|
|
2014
Q2 | $18.9M | Hold |
1,067,892
| – | – | 7.36% | 4 |
|
|
2014
Q1 | $21.4M | Sell |
1,067,892
-3,000,000
| -74% | -$60M | 8.34% | 5 |
|
|
2013
Q4 | $68.3M | Sell |
4,067,892
-1,553,531
| -28% | -$26.1M | 34.97% | 2 |
|
|
2013
Q3 | $59.7M | Hold |
5,621,423
| – | – | 36.62% | 2 |
|
|
2013
Q2 | $31.4M | Buy |
+5,621,423
| New | +$31.4M | 25.52% | 3 |
|